ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

White House Staff Member Reportedly Says Political Screening Being Carried Out On NCAB Nominations

May 28, 1982

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

NCI Programs:Institute Informs Public About Thyroid Cancer Risk From Fallout.

January 3, 2003

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003